Details for New Drug Application (NDA): 018422
✉ Email this page to a colleague
The generic ingredient in LOPID is gemfibrozil. Thirty-four suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.
Summary for 018422
Tradename: | LOPID |
Applicant: | Pfizer Pharms |
Ingredient: | gemfibrozil |
Patents: | 0 |
Pharmacology for NDA: 018422
Mechanism of Action | Peroxisome Proliferator-activated Receptor alpha Agonists |
Medical Subject Heading (MeSH) Categories for 018422
Suppliers and Packaging for NDA: 018422
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LOPID | gemfibrozil | CAPSULE;ORAL | 018422 | NDA | Parke-Davis Div of Pfizer Inc | 0071-0737 | 0071-0737-20 | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) |
LOPID | gemfibrozil | TABLET;ORAL | 018422 | NDA | Parke-Davis Div of Pfizer Inc | 0071-0737 | 0071-0737-20 | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Nov 20, 1986 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 018422
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription